Gunsynd plc

("Gunsynd" or the "Company")

Employee Benefit Trust

Gunsynd Plc (AIM: GUN, AQSE: GUN) previously announced on 26 January 2021 the finalisation of a Company employee benefit trust called the Gunsynd Employee Benefit Trust ("EBT") which currently holds 15,000,000 ordinary shares in the Company.

The Company today further announces that the trustees of the EBT, LGL Trustees Jersey intend to subscribe for an additional 15,000,000 new ordinary shares ("New Ordinary Shares") in the Company, at par value per New Ordinary Share at an aggregate cost to the Company of £12,750.  Such New Ordinary Shares will represent approximately 3.4% of the issued share capital of the Company following admission of the New Ordinary Shares. Following admission of the New Ordinary Shares, the EBT will hold 30,000,000 ordinary shares representing approximately 7% of the issued share capital of the Company.

Admission to AIM

Application will be made for the new ordinary shares which are to be issued in respect of this subscription to be admitted to trading on AIM ("Admission"). It is expected that Admission of the New Ordinary Shares will become effective at 8.00 a.m. on or around 3 June 2021. The New Ordinary Shares will be issued credited as fully paid and will rank in full for all dividends and other distributions declared, made or paid after Admission and will otherwise rank on Admission pari passu in all respects with the existing ordinary shares.

Total Voting Rights

Following Admission, the Company's issued share capital will comprise 440,711,896 Ordinary Shares with voting rights. The Company does not hold any Ordinary Shares in treasury. The figure of 440,711,896 Ordinary Shares may therefore be used by shareholders in the Company as the denominator for the calculations by which they will determine if they are required to notify their interest in, or a change in their interest in, the share capital of the Company under the FCA's Disclosure and Transparency Rules.

This announcement contains inside information for the purposes of the UK Market Abuse Regulation and the Directors of the Company are responsible for the release of this announcement.

For further information please contact: